Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ECT in primary and secondary depression.

C F Zorumski, J L Rutherford, W J Burke

    The Journal of Clinical Psychiatry
    |June 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Plutonium mobility and reactivity in a heterogeneous clay rock barrier accented by synchrotron-based microscopic chemical imaging.

    Scientific reports·2024
    Same author

    Do perchlorate and triflate anions bind to the uranyl cation in an acidic aqueous medium? A combined EXAFS and quantum mechanical investigation.

    Chemphyschem : a European journal of chemical physics and physical chemistry·2013
    Same author

    Ammonia inhibits long-term potentiation via neurosteroid synthesis in hippocampal pyramidal neurons.

    Neuroscience·2013
    Same author

    Functional network dysfunction in anxiety and anxiety disorders.

    Trends in neurosciences·2012
    Same author

    Hydrophobic anions potently and uncompetitively antagonize GABA(A) receptor function in the absence of a conventional binding site.

    British journal of pharmacology·2011
    Same author

    Structurally diverse amphiphiles exhibit biphasic modulation of GABAA receptors: similarities and differences with neurosteroid actions.

    British journal of pharmacology·2010
    Same journal

    Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

    The Journal of clinical psychiatry·2026
    Same journal

    Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

    The Journal of clinical psychiatry·2026
    Same journal

    Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

    The Journal of clinical psychiatry·2026
    Same journal

    Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

    The Journal of clinical psychiatry·2026
    Same journal

    Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

    The Journal of clinical psychiatry·2026
    Same journal

    The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

    The Journal of clinical psychiatry·2026
    See all related articles

    Electroconvulsive therapy (ECT) effectively treats primary unipolar and bipolar depression. However, response rates vary significantly in secondary depression, with specific conditions like alcoholism and schizophrenia showing better outcomes.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Clinical Psychology

    Background:

    • Major depression is a significant mental health condition with varying treatment responses.
    • Electroconvulsive therapy (ECT) is a recognized treatment for severe depression.
    • Understanding differential treatment efficacy across depression subtypes is crucial for personalized medicine.

    Purpose of the Study:

    • To investigate the efficacy of Electroconvulsive Therapy (ECT) in patients diagnosed with major depression.
    • To compare ECT response rates across different diagnostic categories of depression: primary unipolar, primary bipolar, and secondary depression.
    • To identify specific primary diagnoses within the secondary depression group that predict a more favorable ECT outcome.

    Main Methods:

    • A cohort of 58 subjects meeting DSM-III criteria for major depression was assessed.

    Related Experiment Videos

  • Patients were categorized into primary unipolar depression, bipolar depression, and secondary depression groups.
  • Remission rates of depressive symptoms following ECT were analyzed across these diagnostic groups.

    • Main Results:

    • High remission rates were observed in primary unipolar depression (91%) and primary bipolar depression (100%).
    • Secondary depression showed a lower partial or complete remission rate (56%).
    • Within the secondary depression group, patients with primary diagnoses of alcoholism and schizophrenia exhibited the most favorable ECT response.

    Conclusions:

    • ECT is a highly effective treatment for primary unipolar and bipolar depression.
    • The efficacy of ECT in secondary depression is less consistent and depends on the underlying primary diagnosis.
    • Further research into the specific mechanisms driving differential ECT response in secondary depression subtypes is warranted.